Compare with other Alzheimer's Medications
Compare
Compare
| Sertraline | VS | All other Alzheimer's Medications |
| Basic Medical Informatin | |||||
|---|---|---|---|---|---|
| Treatment For | Depression, Obsessive-compulsive Disorder, Panic Disorder, Anxiety Disorders, Post-traumatic Stress Disorder (ptsd), And Premenstrual Dysphoric Disorder (pmdd) | ||||
| Legal Status | Rx-only | ||||
| Pregnancy cat. | C (US) | ||||
| Possible Side Effects | Fever, Sweating, Confusion, Fast Or Uneven Heartbeats, Agitation, Hallucinations, Fever, Overactive Reflexes, Tremors, Nausea, Vomiting, Diarrhea, Loss Of Appetite, Feeling Unsteady, Loss Of Coordination, Or Headache, Trouble Concentrating, Memory Problems, Weakness, Fainting, Seizure, Shallow Breathing | ||||
| Precautions & Contraindications | Hypomania And Seizure Disorders, Liver Or Kidney Damage, Heart Disease, Recent Heart Attack, Bleeding Disorders, Diabetes And Angle-closure Glaucoma | ||||
| Excretion | Renal | ||||
| Storage Conditions | 15-30°C | ||||
| Dosage, Usage and Forms | |||||
|---|---|---|---|---|---|
| Forms | Tablet | ||||
| Routes (of administration) | Oral | ||||
| Dosage |
50 mg (23.82 mg lower than average)
|
vs |
73.82 mg
|
||
| Chemical Data | |||||
|---|---|---|---|---|---|
| Bioavailability |
44 % (37.62 % lower than average)
|
vs |
81.62 %
|
||
| Protein binding |
99 % (23.83 % higher than average)
|
vs |
75.17 %
|
||
| Metabolism | Hepatic | ||||
| Half Life (hours) | Approximately 26 H | ||||
| Formula | C17h17cl2n | ||||
| Molecular mass (g/mol) | 306.229 G/mol | ||||